Lung cancer combo therapy study halted early – what we learned
NCT ID NCT03348748
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This study looked at giving a precise, high-dose form of radiation (SBRT) before surgery for people with stage I to IIIA non-small cell lung cancer. The main goal was to see how safe this combination was by tracking serious side effects. The study was stopped early, but the information gathered helps researchers understand the risks and benefits of this approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II NON-SMALL CELL LUNG CANCER AJCC V7 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.